Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0K2HA
|
|||
Former ID |
DIB004789
|
|||
Drug Name |
PF-2413873
|
|||
Synonyms |
PF-02413873
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Endometriosis [ICD-11: GA10; ICD-10: N80, N80.9; ICD-9: 617] | Phase 1 | [1] | |
Company |
Pfizer Inc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H21N3O3S
|
|||
Canonical SMILES |
CC1=CC(=CC(=C1C#N)C)OC2=C(N(N=C2C3CC3)CS(=O)(=O)C)C
|
|||
InChI |
1S/C18H21N3O3S/c1-11-7-15(8-12(2)16(11)9-19)24-18-13(3)21(10-25(4,22)23)20-17(18)14-5-6-14/h7-8,14H,5-6,10H2,1-4H3
|
|||
InChIKey |
QSFGZNVRVZHUGV-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 936345-35-6
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Progesterone receptor (PGR) | Target Info | Antagonist | [2] |
KEGG Pathway | Oocyte meiosis | |||
Progesterone-mediated oocyte maturation | ||||
Pathway Interaction Database | Cellular roles of Anthrax toxin | |||
Reactome | Nuclear signaling by ERBB4 | |||
Nuclear Receptor transcription pathway | ||||
WikiPathways | Ovarian Infertility Genes | |||
Signaling by ERBB4 | ||||
Nuclear Receptors |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00800618) A Study To Investigate How The Body Handles Multiple Doses Of PF-0243873 And To Investigate The Effect Of PF-02413873 On Sex Hormone Levels In Healthy Young Women. U.S. National Institutes of Health. | |||
REF 2 | Unusual base-catalyzed exchange in the synthesis of deuterated PF-2413873. Journal of Labelled Compounds. 08/2009; 52(10):435 - 442. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.